Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lupin acquires Hormosan in Germany

This article was originally published in Scrip

Executive Summary

Lupinhas acquired the German sales and marketing company Hormosan Pharma, for an undisclosed sum. The acquisition, Lupin's first in Europe, establishes a bridgehead in Germany, through which the Indian company expects to launch a range of products. Lupin's managing director, Dr Kamal Sharma, said that Lupin had never "chased size but only strategic fit" and Hormosan offered just that. "We have made a modest investment. Hormosan is a lean smart machine making modest profits," Dr Sharma said at a press conference in Mumbai.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts